Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

NCT03513328 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Bone Marrow Failure Syndrome
Thalassemia
Sickle Cell Disease
Diamond Blackfan Anemia
Acquired Neutropenia in Newborn
Acquired Anemia Hemolytic
Acquired Thrombocytopenia
Hemophagocytic Lymphohistiocytoses
Wiskott-Aldrich Syndrome
Chronic Granulomatous Disease
Common Variable Immunodeficiency
X-linked Lymphoproliferative Disease
Severe Combined Immunodeficiency
Hurler Syndrome
Mannosidosis
Adrenoleukodystrophy

Interventions

DRUG: Thiotepa--single daily dose
DRUG: Thiotepa--escalated dose

Sponsor

University of Florida

Collaborators

[object Object]